Taiwan FDA warns against honey drink found to contain methoxsalen

11/12/2021 08:27 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Nov. 12 (CNA) Taiwan's Food and Drug Administration (FDA) said Friday that buyers of Atomy Corp.'s HemoHIM honey drink should stop using it after it was found to contain methoxsalen, a medication that potentially causes liver damage.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.